BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19761555)

  • 1. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
    Rostaing L; Cointault O; Marquet P; Josse AG; Lavit M; Saint-Marcoux F; Kamar N
    Transpl Int; 2010 Feb; 23(2):227-30. PubMed ID: 19761555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
    J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Falsely elevated tacrolimus concentrations measured using the ACMIA method due to circulating endogenous antibodies in a kidney transplant recipient.
    D'Alessandro M; Mariani P; Mennini G; Severi D; Berloco P; Bachetoni A
    Clin Chim Acta; 2011 Jan; 412(3-4):245-8. PubMed ID: 21059349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
    Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
    Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R; Chusney G; Loucaidou M; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
    Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
    Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review.
    Taguchi K; Ohmura T; Ohya Y; Horio M; Furukawa K; Jono H; Inomata Y; Saito H
    Exp Clin Transplant; 2014 Oct; 12(5):474-8. PubMed ID: 24206050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
    Hashi S; Masuda S; Kikuchi M; Uesugi M; Yano I; Omura T; Yonezawa A; Fujimoto Y; Ogawa K; Kaido T; Uemoto S; Matsubara K
    Transplant Proc; 2014 Apr; 46(3):758-60. PubMed ID: 24767342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antibody-conjugated magnetic immunoassay and liquid chromatography-tandem mass spectrometry for the measurement of cyclosporine and tacrolimus in whole blood.
    Cangemi G; Barco S; Bonifazio P; Maffia A; Agazzi A; Melioli G
    Int J Immunopathol Pharmacol; 2013; 26(2):419-26. PubMed ID: 23755756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays.
    Freire A; Hermida J; Tutor JC
    Ups J Med Sci; 2008; 113(1):103-10. PubMed ID: 18521804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.
    Moscato D; Nonnato A; Adamo R; Vancheri M; Caropreso A
    Clin Chim Acta; 2010 Jan; 411(1-2):77-80. PubMed ID: 19835852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results.
    Hermida J; Tutor JC
    Ther Drug Monit; 2009 Apr; 31(2):269-72. PubMed ID: 19258927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus].
    Chung JW; An D; Song J; Chung HJ; Park HI; Lee W; Chun S; Min WK
    Korean J Lab Med; 2009 Oct; 29(5):415-22. PubMed ID: 19893350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.